Stealth BioTherapeutics
(NASDAQ) MITO
Stealth BioTherapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$54.29M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
MITO News
MITO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Stealth BioTherapeutics
Industry
Biotechnology
Sector
Health CareEmployees
38
CEO
Irene P. McCarthy
Website
www.stealthbt.comHeadquarters
George Town, KY1-9005, KY
MITO Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
2%
Return on Capital
-1%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$51.28M
EBITDA
$51.21M
Operating Cash Flow
$44.97M
Capital Expenditure
$67.00K
Free Cash Flow
$45.04M
Cash & ST Invst.
$47.13M
Total Debt
$13.66M
Stealth BioTherapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
38
N/A
Net Income
$2.66M
+65.4%
EBITDA
$2.12M
+42.8%
Quarterly Fundamentals
Net Cash
$20.05M
-19.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$13.78M
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-1.07%
N/A
Return on Invested Capital
-1.30%
N/A
Free Cash Flow
$35.30M
-762.4%
Operating Cash Flow
$35.25M
-761.6%